- Home
- EBC vs AMRX Comparison
EBC vs AMRX Comparison
Compare EBC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBC | AMRX |
|---|---|---|
| Founded | 1818 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.0B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBC | AMRX |
|---|---|---|
| Price | $19.42 | $13.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $21.88 | $13.25 |
| AVG Volume (30 Days) | ★ 1.8M | 1.6M |
| Earning Date | 01-22-2026 | 02-27-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | 0.02 |
| Revenue | $627,584,000.00 | ★ $2,934,959,000.00 |
| Revenue This Year | $28.16 | $9.99 |
| Revenue Next Year | $32.65 | $6.48 |
| P/E Ratio | ★ $79.56 | $714.51 |
| Revenue Growth | 3.01 | ★ 9.50 |
| 52 Week Low | $13.51 | $6.69 |
| 52 Week High | $20.19 | $13.49 |
Technical Indicators
Market Signals| Indicator | EBC | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 65.78 |
| Support Level | $18.81 | $12.66 |
| Resistance Level | $19.47 | $13.34 |
| Average True Range (ATR) | 0.41 | 0.32 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 69.81 | 87.01 |
Price Performance
Historical ComparisonAbout EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.